Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (171-180 of 243) with videos related to

Pageof 25
Sort By:
Cancers|November 4, 2020
Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain MetastasesMatthias Schneider, Muriel Heimann, Christina Schaub, et al.
Cancers|July 20, 2021
Combined Assessment of Preoperative Frailty and Sarcopenia Allows the Prediction of Overall Survival in Patients with Lung Cancer (NSCLC) and Surgically Treated Brain MetastasisInja Ilic, Anton Faron, Muriel Heimann, et al.
Immunity|April 2, 2026
Microglia-glioblastoma crosstalk mediates glioblastoma invasion at the far infiltration zoneFelix C Nebeling, Falko Fuhrmann, Manuel Mittag, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Scientific Reports|February 16, 2023
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendationsMarco M E Vogel, Arthur Wagner, Jens Gempt, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective AnalysisJulian P Layer, Katharina Layer, Gustavo R Sarria, et al.
Stem Cells (Dayton, Ohio)|February 8, 2013
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastomaMartin Glas, Christoph Coch, Daniel Trageser, et al.
Annals of Neurology|March 13, 2010
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphomaAnnika Juergens, Hendrik Pels, Sabine Rogowski, et al.
Neuro-Oncology|November 14, 2025
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastomaThomas Zeyen, Inga Krause, Andreas Decker, et al.
Molecular Oncology|December 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibitionElena N C Schmidt, Bernd O Evert, Barbara E F Pregler, et al.
Pageof 25

Showing results (171-180 of 243) with videos related to

Sort By:
Pageof 25
Cancers|November 4, 2020
Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain MetastasesMatthias Schneider, Muriel Heimann, Christina Schaub, et al.
Cancers|July 20, 2021
Combined Assessment of Preoperative Frailty and Sarcopenia Allows the Prediction of Overall Survival in Patients with Lung Cancer (NSCLC) and Surgically Treated Brain MetastasisInja Ilic, Anton Faron, Muriel Heimann, et al.
Immunity|April 2, 2026
Microglia-glioblastoma crosstalk mediates glioblastoma invasion at the far infiltration zoneFelix C Nebeling, Falko Fuhrmann, Manuel Mittag, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Scientific Reports|February 16, 2023
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendationsMarco M E Vogel, Arthur Wagner, Jens Gempt, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective AnalysisJulian P Layer, Katharina Layer, Gustavo R Sarria, et al.
Stem Cells (Dayton, Ohio)|February 8, 2013
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastomaMartin Glas, Christoph Coch, Daniel Trageser, et al.
Annals of Neurology|March 13, 2010
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphomaAnnika Juergens, Hendrik Pels, Sabine Rogowski, et al.
Neuro-Oncology|November 14, 2025
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastomaThomas Zeyen, Inga Krause, Andreas Decker, et al.
Molecular Oncology|December 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibitionElena N C Schmidt, Bernd O Evert, Barbara E F Pregler, et al.
Pageof 25